NIGHAT SAEED: Open Payments
NPI 1780086355 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,071 in 39 payments from 13 companies in 2025. Trend: 2023 $4,513 · 2024 $6,629 · 2025 $6,071
Speaker / faculty: $4,000Travel & lodging: $1,314Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $5,436 |
| GENZYME CORPORATION | 8 | $247 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $102 |
| Ardelyx, Inc. | 2 | $53 |
| PFIZER INC. | 3 | $49 |
| Boston Scientific Corporation | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Olympus America Inc. | 1 | $24 |
| QOL Medical, LLC | 1 | $24 |
Products named: CREON, DUPIXENT, XIFAXAN, IBSRELA, XELJANZ, General - Pain Management, VOQUEZNA, OMVOH.
Industry payments across NY — which companies pay providers there.
